DKSH and Roche Extend Existing Strategic Partnership in Vietnam

DKSH has successfully extended its 22-year partnership with Roche, the world’s largest biotechnology company and the global leader in in-vitro diagnostics, to continuing its track record of being the trusted partner to Roche in Vietnam.

Ho Chi Minh City, June 21, 2023 – DKSH Business Unit Healthcare, a leading Market Expansion Services provider for companies seeking to grow their healthcare business in Asia and beyond, has signed an extended agreement with Roche Vietnam to strengthen its business growth. As part of the partnership, DKSH will continue to provide integrated and tailor-made services to Roche in Vietnam, helping to increase accessibility to high-quality diagnostic instruments, reagents, and consumables across the market.

In more than 100 countries, Roche offers the industry’s most comprehensive in-vitro diagnostic solutions to improve the lives of people and patients. As part of Roche Group, Roche Vietnam integrates diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. With a demand for the highest quality assurance for its diagnostic products, Roche has entrusted DKSH to warehousing and logistics services across Vietnam.

"DKSH has offered comprehensive solutions combined with global experience and local understanding for our sustainable development in Vietnam over the past 22 years. This partnership extension helps us cater to our customers’ and patients’ needs with diagnostics solutions." said Dr. Qadeer Raza, General Manager, Roche Vietnam.

Phillip Wray, Vice President, Business Unit Healthcare and Head Country Management, DKSH Vietnam, stated: "As the trusted partner, DKSH continues to improve our best-in--class services to consistently deliver growth for Roche in Vietnam, while fulfilling our purpose of enriching people’s lives and providing high-quality healthcare to our patients. The long-term partnership with Roche Vietnam is a testament to our service capabilities as a leading Market Expansion Services provider in Asia and beyond.”

About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 37 markets with 32,600 specialists, generating net sales of CHF 11.3 billion in 2022. The DKSH Business Unit Healthcare is a trusted healthcare solutions partner across Asia and beyond. With around 7,990 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2022. www.dksh.com/hec

About Roche Vietnam
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalized healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.

In recognizing our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work.

Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

For more information, please visit www.roche.com.